Pronominit hän ja tämä tekstissä

Zusammenfassung: Die Pronomen hän ,er, sie und tämä ,diese(r/s) im Textzusammenhang

Doses de lodo de esgoto compostado em produção de tapete de grama esmeralda imperial

A eficiência da adubação nitrogenada para gramados pode ser aumentada com a utilização de fontes de liberação lenta, como composto de lodo de esgoto, que, em razão das suas características, pode ser um substituto de parte ou do total da adubação inorgânica para as gramas. Não foram encontrados resultados referentes à utilização de lodo compostado na cultura da grama, no Brasil. Objetivou-se com este trabalho avaliar o efeito de doses de composto de lodo de esgoto na produção da grama esmeralda Imperial. Os tratamentos foram constituídos de cinco doses de composto de lodo de esgoto (0, 12, 24, 36 e 48 Mg ha-1, base seca), mais um tratamento com adubação inorgânica (300 kg ha-1 N, 80 kg ha-1 P2O5 e 200 kg ha-1 K2O). Os compostos orgânicos presentes no composto têm diferentes taxas de mineralização, liberando aos 120 dias após a aplicação do lodo mais Mg (100 %), K (90 %) e N (67 %) do que S (57 %), P (40 %) e Ca (31 %). A utilização do composto de lodo na cultura da grama Imperial proporcionou adequado fornecimento de nutrientes, quando aplicado superficialmente, em doses maiores que 36 Mg ha-1. As doses de composto proporcionaram, após a colheita do tapete, aumento linear da acidez potencial e do teor de matéria orgânica, P, S, Fe, Cu, Mn, Zn, As, Cu e Ni e redução linear do pH, do teor de Ca e Mg e da saturação por bases do solo. O aumento das doses do composto de 0 a 48 Mg ha-1 reduziu a massa dos tapetes de grama, atingindo valores de 4,0 kg/tapete, quando a maior dose foi aplicada. Altas doses também proporcionaram os maiores valores de resistência dos tapetes na ordem de 35 e 33 kgf, com as doses de 36 e 48 Mg ha-1, respectivamente.

Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients

Background And Objectives: Isolated limb perfusion with TNF-alpha and melphalan (TM-ILP) is a limb salvage therapy for non-resectable soft tissue sarcomas (STS) of the extremities. It is indicated for patients for whom amputation or debilitating surgery is the only alternative. It can be used either as an exclusive therapy (in palliation) or as a neo-adjuvant treatment, followed by marginal resection of tumor remnants with minimal functional impairment. Methods: Between February 1992 and March 2006, 57 TM-ILPs were performed on 51 patients with 88% high grade and 84% advanced stage tumors. Results: Mean follow-up is 38.9 months (4-159, median 22 months). Twenty-one percent patients had significant early complications, with 3 major re-operations, and 23% suffered long-lasting complications. Complete response was observed in 25%, partial response in 42%, stable disease in 14% and progressive disease in 14%. Resection of the tumor remnants was possible in 65%. A complementary treatment was necessary in 31%, mostly radiation therapy. A local recurrence was observed in 35%, after a mean of 20.3 months (2-78), and distant relapse was seen in 45%, after a mean of 13.4 months (5-196). Mean Disease-free survival was 14.9 months, and overall 5-year-survival 43.5%. Amputation rate at 5 years was 24%. Conclusions: TM-ILP is a conservative treatment with a high complications rate, but it can be successful even for the most severe STS of extremities. As a consequence the limb can be spared from amputation or debilitating surgery on the long term in about 75% of patients

European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries.

BACKGROUND: The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. METHODS: Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. RESULTS: The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). CONCLUSION: The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM.

Collection de copies de pièces sur l'histoire de France, formée par François DE CAMPS, abbé de Signy (1723). II PROVINCES. 57 Lyon et Lyonnais.

« De la souveraineté des rois de France sur la ville et le comté de Lion » (fol. 2, 93, 120) : pièces justificatives, 942-1320 (132, 183). — Lettre critique sur l'Histoire civile ou consulaire de la ville de Lyon du P. Menestrier (90). — Primatie de Lyon (186). Extraits « ex cartulario episcopatus Diensis, quod est conventus fratrum Minimorum Parisiensium, » 1158-1229 (193). Diplômes de l'empereur Frédéric II, copies extraites des archives du Domaine royal en Languedoc, arm. B (196). Inventaire des chartes du Trésor relatives au Lyonnais (218).

Troponine : les faux positifs

Introduction: La troponine est un marqueur biologique bien reconnupour sa cardiospécificité et la détection précoce de la nécrosemyocardique. Le dosage de la troponine fait partie de la stratificationdu syndrome coronarien aigu (SCA) et est fréquemment utilisé dans lebilan initial lors de douleurs thoraciques. Cependant, d'autrespathologies sont également associées à une élévation de la troponine.Le but de ce travail est de décrire les diagnostics retenus chez despatients admis aux urgences avec une douleur thoracique et uneélévation de la troponine.Méthode: Durant une période de 18 mois (de novembre 2008 à mai2010), 1242 patients admis aux urgences avec une douleur thoraciqueont eu un dosage de la troponine positive (>= 0,1 microg/l). Undiagnostic de SCA a été posé chez 709 patients (57%). Chez les533 autres patients (43%) un autre diagnostic a été retenu.Résultats: Les 533 patients (295 hommes, âge moyen 71 ± 19 anset 238 femmes, 77 ±16 ans) présentaient une valeur de troponinemoyenne (TM) à 1,12 ± 4 microg/l. Parmi ce collectif, 192 patients(36%) avaient un diagnostic d'insuffisance cardiaque (TM 1,18microg/l), 118 patients (22%) un diagnostic autre (anémie, AVC, chutesans traumatisme) (TM 1,65 microg/l), 46 patients (8%) présentaientune pneumonie (TM 0,95 microg /l), 45 patients (8%) une arythmiecardiaque sans signes de décompensation cardiaque (TM 0,42 microg/l), 35 patients (6,5%) un traumatisme (TM 0,52 microg /l), 25 patients(4,7%) une insuffisance rénale sévère (TM 0,74 microg /l), 23 patients(4%) une insuffisance respiratoire (BPCO, fibrose pulmonaire, autrespneumopathies) (TM 1,63 microg /l), 23 patients (4,3%) un contexteinfectieux (choc septique, bactériémie) (TM 0,96 microg /l), 18 patients(3%) une embolie pulmonaire (TM 0,30 microg /l) et 8 patients (1,5%)un Takotsubo ou angor de prinzmétal (TM 1,73 microg /l).A signaler que la TM pour les 709 patients présentant un diagnostic deSCA était de 3,61 microg /l.Conclusion: Ce travail montre que près de 50% des patients arrivantaux urgences avec une douleur thoracique et une troponine positive ontun diagnostic autre qu'un SCA.